A collaborative study from the University of Cologne has uncovered how a key mitochondrial protein, AIFM1 (Apoptosis-Inducing Factor ...

A collaborative study from the University of Cologne has uncovered how a key mitochondrial protein, AIFM1 (Apoptosis-Inducing ...

Fat isn’t just a guilty pleasure — it’s cancer’s secret weapon. New research from UT Southwestern Medical Center is shedding ...

Scinai Immunotherapeutics (NASDAQ: SCNI) , a biopharma company focused on inflammation and immunology, announced that Dr. Roberta Lotti of Pincell Sr ...

A newly identified long noncoding RNA (lncRNA), named lnc2300, plays a protective role in ovarian granulosa cells but is ...

While chemotherapy can be lifesaving, it also damages DNA and leads to cognitive issues known as "chemo brain." These effects ...

Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) ...

The tumor suppressor p53 is a transcription factor that controls the expression of hundreds of genes. Emerging evidence suggests that the p53-induced RNA-binding protein ZMAT3 is a key splicing ...

John Mascarenhas, MD, discusses the rationale, mechanism, and design of the phase 1 INCA33989-101 and -102 trials investigating a CAL-R–targeted antibody for patients with essential thrombocythemia.

Major depressive disorder affects hundreds of millions worldwide, but a key to understanding its origins may lie in the brain ...

CAR-T cells, which are genetically programmed to specifically recognize and kill target cells, have altered the therapeutic ...